Learn

Cardiometabolic syndrome (CMS) is a complex interplay of metabolic dysregulation, cardiovascular disease and diabetes risk factors. It encompasses obesity, insulin resistance, dyslipidaemia, hyperuricemia, and hypertension, with obesity triggering metabolic disturbances. The global prevalence of CMS is driven by rising obesity rates and sedentary lifestyles.

The metrics on the metabolic health of Australians are concerning and suggest an emerging crisis:

• 67% of Australian adults and 25% of Australian children are overweight or obese
• 1 in 4 Australians have NAFLD
• 1 in 20 Australians (or 1.3 million) Australians have type 2 diabetes
• 97,000 Australians are estimated to have bariatric surgery in 2024
• 5 million Australians take statins to manage cholesterol

This one-day event explores the key issues and latest research on cardiometabolic disorders with a focus on evidence-based, effective dietary, nutritional and lifestyle approaches to treatment.

The information will be presented by leading clinicians and academics in this field – Dr. Ross Walker, Dr. Michelle Woolhouse, Dr. Elizabeth Steels, Dr. Brad McEwen, Dr. Arun Dhir and Rebecca Edwards.

Restoration of metabolic health is possible with the right information, tools and approaches.

You will learn how to assess, prevent, manage and restore metabolic health

KEY TOPICS INCLUDE:

• Continual glucose monitoring – understand how to interpret the metrics of this powerful behaviour modification tool
• Protocols for effective blood sugar management
• The latest research on statins, cholesterol and the microbiome
• Nutritional strategies to support post-surgery deficiencies in bariatric patients
• The misconceptions and myths of cholesterol and an evidence-based approach to its effective management
• GLP-1 agonists: the promise and the risks that accompany these medicines.

Learning Outcomes

1. Analyse the role of the microbiome in regulating obesity and cholesterol, and how it is affected by bariatric surgery
2. Identify key drivers of metabolic dysfunction, and evaluate the latest research on how dietary, lifestyle, and supplementation protocols can influence disease prevention and management
3. Explain the metabolic links between Alzheimer's disease and nutrition, and explore how nutritional interventions can be used to support cognitive health
4. Evaluate the mechanism of action, potential side effects, and contraindications of GLP-1 agonists, as well as how to effectively guide patients using these treatments.

Details

EVENT DETAILS:

Venue: Aerial UTS Function Centre, Building 10, Level 7/235 Jones St, Ultimo, NSW

Date: Saturday, 19 October 2024

Face-to-face & live streamed event, recording available post event

DIRECTIONS TO VENUE

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard.